Discontinuation report BLES
Report ID | 143216 |
Drug Identification Number | 02245464 |
Brand name | BLES |
Common or Proper name | bovine lipid extract surfactant |
Company Name | BLES BIOCHEMICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | SURFACTANT-ASSOCIATED PROTEINS SP-B AND SP-C PHOSPHOLIPID |
Strength(s) | 500MCG 27MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRATRACHEAL INTRATRACHEAL |
Packaging size | 4 mL |
ATC code | R07AA |
ATC description | OTHER RESPIRATORY SYSTEM PRODUCTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-12-31 |
Actual discontinuation date | 2021-12-31 |
Remaining supply date | 2021-12-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | 3 mL and 5 mL sizes remain available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 60 PACIFIC COURT LONDON, ONTARIO CANADA N5V 3K4 |
Company contact information | 8-60 Pacific Court London, Ontario Canada N5V 3K4 Tel: 519-457-2537 Email: info@blesbiochem.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-01-04 | French | Compare |
v8 | 2022-01-04 | English | Compare |
v7 | 2021-08-10 | French | Compare |
v6 | 2021-08-10 | English | Compare |
v5 | 2021-08-10 | French | Compare |
v4 | 2021-08-10 | English | Compare |
v3 | 2021-08-10 | English | Compare |
v2 | 2021-08-10 | English | Compare |
v1 | 2021-07-29 | English | Compare |
Showing 1 to 9 of 9